MVEIX | VEVYX | MVEIX / VEVYX | |
Total Expense Ratio | 1.47 | 0.66 | 223% |
Annual Report Gross Expense Ratio | 1.47 | 0.66 | 223% |
Fund Existence | 27 years | 13 years | - |
Gain YTD | 7.419 | 1.133 | 655% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 1000000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.1M | 17.2B | 0% |
Annual Yield % from dividends | 1.01 | 1.08 | 93% |
Returns for 1 year | -0.45 | -7.20 | 6% |
Returns for 3 years | 5.17 | -2.80 | -185% |
Returns for 5 years | 11.09 | 34.80 | 32% |
Returns for 10 years | -26.23 | 45.03 | -58% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 27.57 | 0.21 | +0.79% |
First Trust Nasdaq Pharmaceuticals ETF | |||
HACK | 82.90 | 0.47 | +0.57% |
Amplify Cybersecurity ETF | |||
IGBH | 24.48 | 0.06 | +0.25% |
iShares Interest Rate Hdg L/T Corp BdETF | |||
SCDS | 56.45 | N/A | N/A |
JPMorgan Fundamental Data Sci Sm Cor ETF | |||
HIO | 3.94 | -0.02 | -0.51% |
Western Asset High Income Opportunity Fund |